All In Biotech

Drug Trial Radar · NCT02542696

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Last checked: Nov 19, 2026Latest source record: Nov 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

496

Actual

Start

Aug 31, 2015

Primary completion

Nov 8, 2022

Study completion Nov 8, 2022

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Sep 7, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Conditions

  • Parkinson Disease

Interventions

  • APL-130277Drug

    Used to treat up to 5 "OFF" episodes per day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of Safety and Tolerability Data Collected, Based on Number of Participants With Adverse Events in the LTS PhaseTime frame: up to approximately 3 years

Locations

70 sites in 8 countries. Site status is shown where the registry gives one.

  • University of Alabama Birmingham

    Birmingham, Alabama

  • Muhammed Ali Parkinson and Movement Disorder Center/Barrow Neurological Institute

    Phoenix, Arizona

  • Movement Disorders Center of Arizona

    Scottsdale, Arizona

  • Clinical Trials, Inc.

    Little Rock, Arkansas

  • The Parkinson's and Movement Disorder Institute

    Fountain Valley, California

  • UC Irvine Health Gottschalk Medical Plaza

    Irvine, California

  • Keck Medical Center at USC

    Los Angeles, California

  • University of Colorado School of Medicine

    Aurora, Colorado

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Parkinsons Disease and Movement Disorders Center

    Boca Raton, Florida

  • University of Miami, Miller School of Medicine

    Miami, Florida

  • Parkinson's Disease Treatment Center of Southwest Florida

    Port Charlotte, Florida

  • Suncoast Neuroscience Associates Inc.

    St. Petersburg, Florida

  • USF Parkinson's Disease and Movement Disorder Center

    Tampa, Florida

  • Emory University Department of Neurology

    Atlanta, Georgia

  • GRU Movement Disorders

    Augusta, Georgia

  • Northwestern University

    Chicago, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • NorthShore Neurological Institute B043D

    Glenview, Illinois

  • Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center

    Winfield, Illinois

  • University of Iowa Dept. of Neurology

    Iowa City, Iowa

  • Kansas University Medical Center-Department of Neurology

    Kansas City, Kansas

  • University of Kentucky

    Lexington, Kentucky

  • University of Maryland

    Baltimore, Maryland

  • Johns Hopkins University

    Baltimore, Maryland

  • Michigan State University - Dept. of Neurology

    East Lansing, Michigan

  • QUEST Research Institute

    Farmington Hills, Michigan

  • Henry Ford Hospital

    West Bloomfield, Michigan

  • Park Nicolet Institute - Stuthers Parkinson's Center

    Golden Valley, Minnesota

  • SUNY Downstate Medical Center, Department of Neurology

    Brooklyn, New York

  • Bendheim Parkinson's and Movement Disorder Center (Mount Sinai Medical Center)

    New York, New York

  • Columbia University Medical Center - Neurological Institute, Movement Disorders

    New York, New York

  • Duke University - Movement Disorders Clinic

    Durham, North Carolina

  • Raleigh Neurology Associates, P.A.

    Raleigh, North Carolina

  • Wake Forest Baptist Health

    Winston-Salem, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • UT Gardner-McMaster Parkinson's Center

    Toledo, Ohio

  • The Movement Disorder Clinic of Oklahoma

    Tulsa, Oklahoma

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.